Pakistan Essential Principles and Declaration of Conformity

1. Key takeaways

Submissions for medical devices in Pakistan must include a statement of conformity with the Essential Principles of Safety and Performance of medical devices, together with the Declaration of Conformity (DoC) signed by the manufacturer. These, along with the technical documentation and the ISO 13485 certificate, make up the evidentiary core of the registration dossier. The Essential Principles function as the reference standard against which the whole dossier is read: every claim the applicant makes about the device ultimately resolves into a claim that some principle of safety and performance has been met, and every supporting document, from the quality system certificate through the test reports to the clinical or performance data, exists to substantiate one or more of those claims. The DoC then places the manufacturer’s signature under the whole structure, converting a body of evidence into a formal legal assertion. Neither document is decorative, and weaknesses in either, a principle left unsupported or a declaration signed by the wrong hand, are among the deficiencies most reliably surfaced during review.

A useful way to understand the pairing is to consider what each document does that the other cannot. The Essential Principles conformity statement is analytical: it decomposes the safety and performance of the device into enumerated principles and says, principle by principle, where the proof lives. The DoC is declaratory: it compresses all of that analysis into a single signed assertion of responsibility, made by an identified legal person. Reviewers need both, the analysis to examine and the assertion to hold someone accountable for, and the dossier is strongest when the two are visibly connected, with the signature of the DoC covering precisely the device, and only the device, that the matrix describes.

• A conformity statement against the Essential Principles of Safety and Performance is required.
• The manufacturer must sign the Declaration of Conformity (DoC).
• The documents specified in the form must accompany the application.
• Reference-authority approval or CE marking can serve as a basis of reliance.
• Labels and prescribing information must match the approved version.
• The certificate carries a number, a 5-year validity, and written reasons on rejection.

2. Legal basis

The provisions below, from the Medical Devices Rules 2017 notified on 16 January 2018, frame the place of the Essential Principles and the DoC inside the dossier: the general duty to attach what the form requires, the reliance pathway for foreign approvals, the verification principle for manufacturing and testing, label consistency, and the grant mechanics of the certificate itself.

3. Expert insights

Insight one: the Essential Principles are the master outline of Pakistani review, and the remaining documents are their support. The core logic of the dossier runs in a single chain: the device conforms to the Essential Principles of Safety and Performance, and the specific evidence for that conformity is the QMS certificate, the certificate of conformity, the test reports and the clinical or performance data. Every reviewer question is, at bottom, a question about a link in that chain. Framing the dossier around the principles first, and then attaching evidence to each principle, means the file answers questions in the order the reviewer is likely to ask them, which is the quietest way to steer a review toward a grant.

Insight two: the correspondence between the Essential Principles and the technical documentation should be built as a matrix. Mapping each principle to its specific support, the standard number, the test report number, the risk management chapter, is the single most effective action for improving review efficiency. Without the matrix, the linkage exists in the authors’ heads but not on paper, and the reviewer must reconstruct it, slowly and uncharitably, from a stack of documents. With it, the reconstruction is done once, by the applicant, and delivered as a map. The matrix also earns its keep after grant: when a principle-relevant change arrives, the matrix identifies immediately which documents must be refreshed.

Insight three: the signatory of the DoC must be consistent with the authorization letter. In practice it is common to find a DoC signed by the head of quality while the authorization letter is signed by the legal representative, and the mismatch raises questions about the validity of the authority under which the declaration was made. The requirement observed in practice is that the DoC and the authorization letter be signed by the same person, or at least be traceable within the same system of authorization. Signature governance sounds like a small point until a deficiency letter asks the question; at that moment, the answer must already exist in the corporate documents, not be improvised in the response.

4. Practical recommendations

• Prepare, for every Pakistan project, an Essential Principles conformity matrix: the left column lists every entry of the Essential Principles, and the right column records, entry by entry, the document number and chapter relied upon.
• Once the matrix is complete, the dossier possesses a clear evidence index, and both review queries and deficiency responses can be located quickly.
• Check the signatory of the DoC against the signatory of the authorization letter before submission, and correct any inconsistency while it is still an internal matter.
• Refresh the matrix whenever standards, test reports or risk management documentation are revised, so the index never points at superseded evidence.

5. Verification checklist

• □ Essential Principles conformity matrix compiled
• □ Every principle supported by a corresponding document
• □ DoC signed by the manufacturer
• □ DoC signatory consistent with, or traceable to, the authorization letter
• □ Technical documentation consistent with the matrix index

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Pakistan. Our team prepares dossiers to DRAP expectations, manages eCTD-format submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com